Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Initial Intervention	STARTED	Remicade	1,541
Initial Intervention	STARTED	Standard Therapy Group	1,121
Initial Intervention	COMPLETED	Remicade	1,023
Initial Intervention	COMPLETED	Standard Therapy Group	800
Initial Intervention	NOT COMPLETED	Remicade	518
Initial Intervention	NOT COMPLETED	Standard Therapy Group	321
Switch to Remicade	STARTED	Remicade	0
Switch to Remicade	STARTED	Standard Therapy Group	298
Switch to Remicade	COMPLETED	Remicade	0
Switch to Remicade	COMPLETED	Standard Therapy Group	249
Switch to Remicade	NOT COMPLETED	Remicade	0
Switch to Remicade	NOT COMPLETED	Standard Therapy Group	49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00705614/flow